AXSOME THERAPEUTICS, INC. Long-Term Debt
AXSOME THERAPEUTICS, INC. (AXSM) had Long-Term Debt of $117.96 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-10
- 2026-06-30: Long-term Debt, Excluding Current Maturities $117.96M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $117.85M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $117.75M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $117.64M.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2026-06-30 | $117.96M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $117.85M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $117.75M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $117.64M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $117.54M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $181.38M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $180.71M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $180.00M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $179.33M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $178.69M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $178.07M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $177.45M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $176.82M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $147.62M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $94.26M 10-K · filed 2024-02-23 | $94.26M 10-K · filed 2023-02-28 |
| 2022-09-30 | $93.91M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $93.46M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $49.31M 10-Q · filed 2022-05-02 | |
| 2021-12-31 | $49.09M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $49.17M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $48.88M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $48.60M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $48.32M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $48.03M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $13.74M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $15.54M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $17.33M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $19.11M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $17.42M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $18.82M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $3.62M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $4.44M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $5.19M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $5.93M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $6.66M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $7.38M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $8.08M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $8.78M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $9.47M 10-K · filed 2018-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |